We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

62 hedge funds and large institutions have $69.8M invested in Marrone Bio Innovations, Inc. in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 8

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

12% more capital invested

Capital invested by funds: $62.3M → $69.8M (+$7.49M)

7% more funds holding

Funds holding: 58 → 62 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
62
Holders Change
+4
Holders Change %
+6.9%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
25
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AAP
Ardsley Advisory Partners
Connecticut
+$1.97M
2
WRF
Waddell & Reed Financial
Kansas
+$1.77M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$546K
4
State Street
State Street
Massachusetts
+$368K
5
BlackRock
BlackRock
New York
+$242K

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$157K
2
Goldman Sachs
Goldman Sachs
New York
-$88.2K
3
Primecap Management
Primecap Management
California
-$62.2K
4
RJA
Raymond James & Associates
Florida
-$59K
5
TRCT
Tower Research Capital (TRC)
New York
-$55.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
MFIM
51
Mesirow Financial Investment Management
Illinois
$4.73K +$4.51K +3,782 New
PAM
52
Panagora Asset Management
Massachusetts
$4K – – –
HFA
53
Hoover Financial Advisors
Pennsylvania
$4K +$3.58K +3,000 New
CFA
54
Carroll Financial Associates
North Carolina
$2K – – –
KFAA
55
Klaas Financial Asset Advisors
Illinois
$2K +$1.97K +1,650 New
GI
56
Gradient Investments
Minnesota
$1K – – –
IA
57
IFP Advisors
Florida
$1K – – –
Osaic Holdings
58
Osaic Holdings
Arizona
$1K – – –
FDCDDQ
59
Federation des caisses Desjardins du Quebec
Quebec, Canada
$625 – – –
AIG
60
American International Group
New York
$50 +$72 +60 +0.1%
RJA
61
Raymond James & Associates
Florida
– -$59K -48,489 Closed
WS
62
Wedbush Securities
California
– -$45K -37,129 Closed
PP
63
Paloma Partners
Connecticut
– -$19K -15,203 Closed
RJFSA
64
Raymond James Financial Services Advisors
Florida
– -$15K -12,641 Closed
HF
65
HRT Financial
New York
– -$14K -11,759 Closed
MAM
66
Meeder Asset Management
Ohio
– -$1K -1,062 Closed
1 2
3

MBII Hedge Fund Activity: Q4 2020 in Review

62 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2020, worth a combined $69.8M — up 12% from $62.3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MBII positions and 6 closed out — a net gain of 5 holders — while 25 added to existing stakes and 8 trimmed.

The largest buyer was Ardsley Advisory Partners, adding an estimated $1.97M. The largest seller was Russell Investments Group, cutting an estimated $157K.

  • 62 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2020, up from 58 in Q3 2020.
  • Funds reported $69.8M of Marrone Bio Innovations, Inc. stock for Q4 2020, up 12% quarter-over-quarter.
  • 11 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2020 and 6 closed out, a net change of +5 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q4 2020 was Ardsley Advisory Partners, an estimated $1.97M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q4 2020 was Russell Investments Group, an estimated $157K sold.

Based on aggregated 13F filings for Q4 2020.